Cabell Christopher

CIK 00018149284 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001814928

Recent Transactions

16 trades

Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Common Stock
2026-02-21−338,282→ 676,564 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2026-01-05+900,117→ 900,117 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-02-21+1,100,705→ 1,100,705 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-02-21+1,100,705→ 1,100,705 total
Award
Zura Bio Ltd$ZURA
Class A Ordinary Shares
2023-05-18+162,060→ 162,060 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2023-01-26+1,700→ 1,700 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2022-01-27+22,100→ 22,100 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2021-01-28+15,000→ 15,000 total
Tax Payment
ARENA PHARMACEUTICALS INC
Common Stock
2020-11-25$65.50/sh−1,099→ 1,401 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2020-11-25+2,500→ 2,500 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Performance Restricted Stock Unit
2020-11-25−2,500→ 5,000 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-07-15−13,000→ 47,000 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2020-07-15$26.28/sh+13,000→ 13,000 total
Sale
ARENA PHARMACEUTICALS INC
Common Stock
2020-07-15$68.00/sh−13,000→ 0 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-06-12+20,000→ 20,000 total

Companies

Recent Filings

Address

1000 N. WEST STREET, SUITE 1200

WILMINGTON, DE, 19801

View on SEC.gov